Tsinocap cream d / pl. approx. 0.2% tube 25g
Category
Psoriasis
,
Acne
Scope of the medicinal product
Leather
Release form
Cream
Manufacturer country
Russia
Minimum age from
1 year
Structure
100 g of cream contains: zinc pyrithione (in terms of 100% substance) - 0.2 g (0.2%).
Excipients: macrogol cetostearate, cetostearyl alcohol
pharmachologic effect
This dermatoprotective drug is characterized by anti-inflammatory, antibacterial and antifungal effects.
The antibacterial activity of the main component is directed to gram-positive and gram-negative bacteria: Streptococcus spp., Escherichia coli, Staphylococcus spp., Pseudomonas aeruginosa and Proteus spp.
In addition, zinc pyrithione is able to lower the intracellular ATP level, leading to depolarization of cell membranes, death of fungi and bacteria.
The antifungal effect is pronounced against Pityrosporum orbiculare and Pityrosporum ovale, which cause inflammation and excessive flaking in dandruff, psoriasis, seborrheic dermatitis and other skin conditions.
Indications
Shown at:
psoriasis, seborrhea, dandruff
eczema
itching
dermatitis
neurodermatitis
inflammation and increased flaking of the skin
diseases caused by the bacteria Pityrosporum, such as versicolor versicolor or seborrheic dermatitis.
Contraindications
- Hypersensitivity.
- Children up to age 1 year.
Side effects
The drug is usually well tolerated.
Allergic reactions are sometimes noted.
Interaction
No clinically significant interaction of zinc pyrithione with other drugs has been identified.
How to take, course and dosage
The drug is intended for external use.
Adults and children from 1 year of age: the cream is applied in a thin layer to the affected areas 2-3 times a day.
Psoriasis: 1-1.5 months, repeated courses - when signs of exacerbation appear.
Atopic dermatitis: 3-4 weeks.
Seborrheic dermatitis: 2 weeks.
Release form
Cream.
Storage conditions
In a dry place, at a temperature of 4-25 ° C
Shelf life
2 years
Name ENG
CINOCAP
Clinical and pharmacological group
Drug with antiproliferative, antibacterial and antifungal effects for external use
ATX code
Pyrithione zinc
Dosage
Zinc pyrithione (in terms of 100% substance) - 0.2 g (0.2%).
Structure
100 g of cream contains: zinc pyrithione (in terms of 100% substance) - 0.2 g (0.2%).
Excipients: macrogol cetostearate, cetostearyl alcohol
Indications
Psoriasis
atopic dermatitis (eczema, neurodermatitis)
seborrheic dermatitis
dry skin.
Storage conditions and periods
The drug should be stored in a dry place at a temperature of 4-25 ° C.
Shelf life is 2 years.
Contraindications
children's age up to 1 year
hypersensitivity to drug components.
INN / Active ingredient
Zinc pyrithione
Specifications
Category
Psoriasis
,
Acne
Scope of the medicinal product
Leather
Release form
Cream
Manufacturer country
Russia
Minimum age from
1 year
Way of introduction
On the skin
Vacation conditions
Without recipe
Brand name
OTCPharm
The amount of the dosage form in the primary package
25 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Dermatoprotective agent
Anatomical and therapeutic characteristics
D11AX12 Zinc pyrithione
Dosage form
Cream for external use
Expiration date in days
36
The target audience
Children
Package weight, g
40
Mode of application
:
The drug is intended for external use.
Adults and children from 1 year of age: the cream is applied in a thin layer to the affected areas 2-3 times a day.
Psoriasis: 1-1.5 months, repeated courses - when signs of exacerbation appear.
Atopic dermatitis: 3-4 weeks.
Seborrheic dermatitis: 2 weeks.
Dosage (volume) of the substance in the preparation
:
Zinc pyrithione (in terms of 100% substance) - 0.2 g (0.2%).